David J. Arthur - Net Worth and Insider Trading
David J. Arthur Net Worth
The estimated net worth of David J. Arthur is at least $6,436 dollars as of 2024-11-05. David J. Arthur is the CEO of Salarius Pharmaceuticals Inc and owns about 4,390 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $6,436. Details can be seen in David J. Arthur's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David J. Arthur has not made any transactions after 2022-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David J. Arthur
David J. Arthur Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David J. Arthur owns 1 companies in total, including Salarius Pharmaceuticals Inc (SLRX) .
Click here to see the complete history of David J. Arthur’s form 4 insider trades.
Insider Ownership Summary of David J. Arthur
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-05-26 | director & Chief Executive Officer |
David J. Arthur Latest Holdings Summary
David J. Arthur currently owns a total of 1 stock. David J. Arthur owns 4,390 shares of Salarius Pharmaceuticals Inc (SLRX) as of May 26, 2022, with a value of $6,436.
Latest Holdings of David J. Arthur
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-05-26 | 4,390 | 1.47 | 6,436 |
Holding Weightings of David J. Arthur
David J. Arthur Form 4 Trading Tracker
According to the SEC Form 4 filings, David J. Arthur has made a total of 5 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 219 shares on May 26, 2022, which cost David J. Arthur around $7,902.
Insider Trading History of David J. Arthur
- 1
David J. Arthur Trading Performance
GuruFocus tracks the stock performance after each of David J. Arthur's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J. Arthur is -12.69%. GuruFocus also compares David J. Arthur's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J. Arthur within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David J. Arthur's insider trading performs compared to the benchmark.
Performance of David J. Arthur
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.38 | | | | | |
| Relative Return to S&P 500(%) | 5.33 | | | | | |
David J. Arthur Ownership Network
Ownership Network List of David J. Arthur
Ownership Network Relation of David J. Arthur
David J. Arthur Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
David J. Arthur is the director & Chief Executive Officer of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , Chief Financial Officer Scott Jordan , and Controller Pao-yu Chuang .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
David J. Arthur Mailing Address
Above is the net worth, insider trading, and ownership report for David J. Arthur. You might contact David J. Arthur via mailing address: 2450 Holcome Blvd., Suite J-608, Houston Tx 77021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
